hydroxyurea has been researched along with azathioprine in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (38.71) | 18.7374 |
1990's | 4 (12.90) | 18.2507 |
2000's | 7 (22.58) | 29.6817 |
2010's | 8 (25.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
McMeekin, TO; Moschella, SL | 1 |
Bogliolo, G; Massa, G; Mitra, G; Pannacciulli, I; Saviane, A | 1 |
Durie, BG; Salmon, SE | 1 |
Baker, H | 1 |
Greenwald, ES | 1 |
Almeyda, J; Levantine, A | 1 |
Dantzig, PI | 1 |
Herzberg, JJ | 1 |
Rossi, A; Sebastio, L; Ventruto, V | 1 |
Didlake, R; Files, JC; Kirchner, KA; Krueger, RP; Raju, S | 1 |
McDonald, CJ | 1 |
Cervantes, F; Esteve, J; Marín, P; Montserrat, E; Rozman, C; Sanz, L; Vilardell, J | 1 |
Berr, F; Halm, U; Mössner, J; Paasch, U; Pönisch, W; Schiefke, I | 1 |
Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P | 1 |
Mignozzi, M; Picca, S | 1 |
Belgi, G; Friedmann, PS | 1 |
Andreani, M; Gaziev, J; Lucarelli, G; Polchi, P; Sodani, P | 1 |
Ciołkiewicz, M; Domysławska, I; Klimiuk, PA; Kowal-Bielecka, O; Lewszuk, A; Sierakowski, S | 1 |
11 review(s) available for hydroxyurea and azathioprine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Iatrogenic complications of dermatologic therapy. Primum non nocere.
Topics: Adrenal Cortex Hormones; Azathioprine; Cryosurgery; Cyclophosphamide; Electrosurgery; Erythromycin; Hexachlorocyclohexane; Humans; Hydroxyurea; Iatrogenic Disease; Methotrexate; Podophyllin; Radiotherapy; Skin Diseases; Tetracycline; Ultraviolet Therapy | 1979 |
Psoriasis: a review. II.
Topics: Adrenal Cortex Hormones; Anthralin; Azathioprine; Azauridine; Fluorouracil; Humans; Hydroxyurea; Lomustine; Mechlorethamine; Methotrexate; Psoriasis; Tars; Tretinoin; Ultraviolet Therapy | 1975 |
Guidelines for management of patients with psoriasis. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow; British Association of Dermatologists.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporins; Humans; Hydroxyurea; Methotrexate; Phototherapy; Psoriasis; Retinoids; Skin | 1991 |
Cancer chemotherapy. II.
Topics: Animals; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Cytarabine; Dactinomycin; Daunorubicin; Dimethylamines; Doxorubicin; Floxuridine; Fluorouracil; Humans; Hydroxyurea; Imidazoles; Mercaptopurine; Mitomycins; Mitotane; Neoplasms; Nitrosourea Compounds; Pipobroman; Procarbazine; Streptonigrin; Streptozocin; Thioguanine; Triazenes; Triazines; Vinblastine; Vincristine | 1972 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Eruptions; Erythema; Fluorouracil; Gynecomastia; Humans; Hydroxyurea; Methotrexate; Photosensitivity Disorders; Pigmentation Disorders; Radiation Injuries; Stomatitis; Vinblastine | 1974 |
Immunosuppressive and cytotoxic drugs in dermatology.
Topics: Animals; Antineoplastic Agents; Azathioprine; Azauridine; Bleomycin; Chlorambucil; Cyclophosphamide; Cytarabine; Dactinomycin; Humans; Hydroxyurea; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Procarbazine; Skin Diseases; Skin Neoplasms; Vinblastine; Vincristine | 1974 |
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
Topics: Anthralin; Azathioprine; Carcinogens; Coal Tar; Humans; Hydroxyurea; Methotrexate; Mutagenicity Tests; Mutagens; Mutation; Probability; Psoriasis; PUVA Therapy; Risk; Salmonella typhimurium | 1981 |
The uses of systemic chemotherapeutic agents in psoriasis.
Topics: Administration, Topical; Anthralin; Azathioprine; Azauridine; Chemical Phenomena; Chemistry; Humans; Hydroxyurea; Mercaptopurine; Mustard Compounds; Mycophenolic Acid; Psoriasis | 1981 |
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors | 1999 |
Traditional therapies: glucocorticoids, azathioprine, methotrexate, hydroxyurea.
Topics: Azathioprine; Dermatologic Agents; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive Agents; Methotrexate; Skin Diseases | 2002 |
20 other study(ies) available for hydroxyurea and azathioprine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Effects of blood letting on the sensitivity of the CFU C57BL/C3H mice to various antineoplastic agents].
Topics: Animals; Antineoplastic Agents; Azathioprine; Bloodletting; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cells; Hydroxyurea; Mice; Nitrosourea Compounds; Vinblastine | 1977 |
Cellular kinetics in multiple myeloma. A new approach to staging and treatment.
Topics: Azathioprine; Bone and Bones; Bone Neoplasms; Cell Count; Computers; Cytarabine; Diagnosis, Computer-Assisted; Doxorubicin; Humans; Hydroxyurea; Immunoglobulin G; Information Systems; Kinetics; Medical Records; Multiple Myeloma; Myeloma Proteins; Prognosis; Vincristine | 1975 |
[Proceedings: Immunosuppression and treatment of psoriasis using cytostatic agents].
Topics: Aged; Antineoplastic Agents; Azathioprine; Bibliographies as Topic; Chemical and Drug Induced Liver Injury; Humans; Hydroxyurea; Immunosuppression Therapy; Male; Methotrexate; Psoriasis | 1973 |
[Chromosome study in 14 psoriatic patients treated with hydroxyurea and azathioprine].
Topics: Adult; Azathioprine; Chromosomes; Humans; Hydroxyurea; Karyotyping; Male; Middle Aged; Mutagens; Psoriasis | 1973 |
Chronic granulocytic leukemia after renal transplantation.
Topics: Adult; Allopurinol; Azathioprine; Humans; Hydroxyurea; Kidney Transplantation; Leukemia, Myeloid; Male; Melphalan; Postoperative Complications; Prednisone | 1983 |
[Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography].
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Hydroxyurea; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Postoperative Complications | 1996 |
[Pyoderma gangrenosum and portal vein thrombosis in a 33-year-old female patient].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents; Ascites; Azathioprine; Bone Marrow Cells; Bone Marrow Examination; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Immunosuppressive Agents; Leukemia, Myelomonocytic, Chronic; Mesenteric Veins; Phenprocoumon; Portal Vein; Prednisolone; Pyoderma Gangrenosum; Splenic Vein; Splenomegaly; Tomography, X-Ray Computed; Venous Thrombosis | 1999 |
Chronic myelogenous leukemia following kidney transplantation in a pediatric patient.
Topics: Adolescent; Antineoplastic Agents; Azathioprine; Human Growth Hormone; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Recombinant Proteins | 2001 |
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical Protocols; Combined Modality Therapy; Comorbidity; Deferoxamine; Disease-Free Survival; Erythrocyte Transfusion; Erythropoietin; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hemosiderosis; Humans; Hydroxyurea; Immunosuppressive Agents; Iron Chelating Agents; Life Tables; Liver Cirrhosis; Male; Phlebotomy; Postoperative Complications; Survival Analysis; Thalassemia; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2005 |
[Coexistence of scleroderma-like syndrome and idiopathic myelofibrosis in a 54-year-old female patient: case report].
Topics: Antineoplastic Agents; Azathioprine; Female; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive Agents; Middle Aged; Prednisone; Primary Myelofibrosis; Raynaud Disease; Scleroderma, Systemic; Treatment Outcome | 2007 |